Latest Articles
Progestin therapy in premenopausal women with incidental meningioma-a narrative review and recommendations for women's health specialists.
To review recent evidence on the association between progestin exposure and meningioma risk and to propose practical recommendations for hormonal management in women requiring progestin therapy.
Published: June 21, 2026, midnight
Associations of surgical menopause and hormone replacement therapy with meningioma development.
Bilateral salpingo-oophorectomy (BSO) and hormone replacement therapy (HRT) exert opposing effects on systemic sex hormone exposure. Although HRT is frequently prescribed following BSO to mitigate surgical menopause, their combined impact …
Published: March 12, 2026, midnight
SAHPRA Issues Warning on Meningioma Risk with Medroxyprogesterone Acetate Use, Updates Product Information - Devdiscourse
SAHPRA Issues Warning on Meningioma Risk with Medroxyprogesterone Acetate Use, Updates Product Information Devdiscourse
Published: Jan. 17, 2025, 4:01 p.m.
Long-term use of certain progestogen drugs may raise risk of intracranial meningioma - MSN
Long-term use of certain progestogen drugs may raise risk of intracranial meningioma MSN
Published: Dec. 2, 2024, 9:18 a.m.
Injectable contraception associated with increased risk of meningioma, say researchers - Pulse
Injectable contraception associated with increased risk of meningioma, say researchers Pulse
Published: April 15, 2024, 7 a.m.
Link copied to clipboard!